Literature DB >> 8350215

Dietary intake and nutritional treatment in childhood Crohn's disease.

A G Thomas1, F Taylor, V Miller.   

Abstract

Dietary intake was assessed in 24 children with active Crohn's disease. Seventeen of the children were sex and height matched with healthy siblings of other patients. The mean energy intake was 1,764 KJ/day (420 kcal/day) lower in patients during relapse than controls (p < 0.05). All 24 children entered a randomised controlled trial of high-dose steroids compared to an elemental diet. The elemental diet was well tolerated orally in most cases; only one patient required nasogastric administration. There was a similar improvement in disease activity and duration of remission in both groups regardless of the site of disease. Subsequent growth velocity was significantly better in the group treated with the elemental diet despite a greater and more sustained increase in energy intake in the group treated with steroids. Reintroduction of specific foods in the elemental diet group initially caused symptoms in three children but were subsequently tolerated. During remission, there was no significant difference in energy intake, but vegetables were consumed significantly less frequently (p < 0.01) and confectionery significantly more frequently (p < 0.05) when patients were compared with their own siblings.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8350215     DOI: 10.1097/00005176-199307000-00011

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  31 in total

Review 1.  Chronic inflammatory bowel disease in children: a complex problem in management.

Authors:  J A Walker-Smith
Journal:  Postgrad Med J       Date:  2000-08       Impact factor: 2.401

Review 2.  Therapy of Crohn's disease in childhood.

Authors:  R M Beattie
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

Review 3.  An update of the role of nutritional therapy in the management of Crohn's disease.

Authors:  Moftah H Alhagamhmad; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  J Gastroenterol       Date:  2012-06-15       Impact factor: 7.527

4.  Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children.

Authors:  Andrew Sawczenko; Omeia Azooz; Joanna Paraszczuk; Maja Idestrom; Nick M Croft; Martin O Savage; Anne B Ballinger; Ian R Sanderson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-06       Impact factor: 11.205

5.  Polymeric formula has direct anti-inflammatory effects on enterocytes in an in vitro model of intestinal inflammation.

Authors:  Naomi S H de Jong; Steven T Leach; Andrew S Day
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

Review 6.  Nutritional status and nutritional therapy in inflammatory bowel diseases.

Authors:  Corina Hartman; Rami Eliakim; Raanan Shamir
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

7.  Nutritional status and food intake in pediatric patients with inflammatory bowel disease at diagnosis significantly differs from healthy controls.

Authors:  Sara Sila; Ivana Trivić; Ana Močić Pavić; Tena Niseteo; Sanja Kolaček; Iva Hojsak
Journal:  Eur J Pediatr       Date:  2019-08-17       Impact factor: 3.183

Review 8.  Nutritional management of Crohn's disease in childhood.

Authors:  R M Beattie
Journal:  J R Soc Med       Date:  1998-03       Impact factor: 5.344

9.  The major pathway by which polymeric formula reduces inflammation in intestinal epithelial cells: a microarray-based analysis.

Authors:  Lily Nahidi; Susan M Corley; Marc R Wilkins; Jerry Wei; Moftah Alhagamhmad; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  Genes Nutr       Date:  2015-07-17       Impact factor: 5.523

10.  Growth Hormone Receptor Gene Expression Increase Reflects Nutritional Status Improvement in Patients Affected by Crohn's Disease.

Authors:  Sara Pagani; Elena Bozzola; Caterina Strisciuglio; Cristina Meazza; Erasmo Miele; M Malamisura; Paola De Angelis; Mauro Bozzola
Journal:  Front Pediatr       Date:  2018-11-12       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.